已核实 DOI 相关产品: 100

Tumor Acidity and Near-Infrared Light Responsive Dual Drug Delivery Polydopamine-Based Nanoparticles for Chemo-Photothermal Therapy

Journal 2021 · IF 18.808 · 31(18): 2009733 · 发表于 2021 年 2 月 26 日
作者: Rangrang Fan,Caili Chen,Huan Hou,Di Chuan,Min Mu,Zhiyong Liu,Ruichao Liang,Gang Guo,Jianguo Xu
阅读全文 在 PubMed 查看

摘要

Photothermal therapy (PTT) combined with chemotherapy, a promising strategy for breast cancer treatment, has a high potential to control drug release, reduce multidrug resistance, and improve therapeutic efficacy. The challenge is how to realize tumor ablation in deeper tissue and NIR-controlled drug delivery. Herein, tumor acidity and near-infrared light (NIR) responsive folic acid (FA) functionalized polydopamine (DPA) nanoparticles (NPs) are developed for doxorubicin (DOX) and epigallocatechin-3-gallate (EGCG) dual delivery. With the assistance of NIR, the cellular uptake of DOX-EGCG/DPA-FA NPs is about three- to sixfold higher when compared with the free DOX group and the control group without NIR irradiation. Moreover, biodistribution study in vivo indicates that DPA-FA NPs can enhance tumoral accumulation, penetration, retention of drugs, and display a ≈ 4- and 19-fold higher intra-tumoral distribution than that of the DPA NPs and free drug groups at 24 h postinjection. Furthermore, 60% of breast cancer-bearing mice survive over 70 days in the DOX-EGCG/DPA-FA NPs group. Additionally, DOX-EGCG/DPA-FA NPs can effectively boost therapeutic efficacy by inducing significant suppression of tumor growth and angiogenesis, and enhancement of apoptosis and necrosis of breast cancer cells. Taken together, DOX-EGCG/DPA-FA NPs may have potential applications as a useful nanoscale vector for enhanced cancer therapy.

本研究中使用的阿拉丁产品

100 款产品在本文中被引用